Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersRadiation Oncology Physician in Aurora, CO
NPI: 1023302148Primary Practice Location
UNIVERSITY OF COLORADO HOSPITAL AUTHORITY
12605 E 16th Ave, Aurora, CO
Primary Employer
University of Colorado Medicine
cumedicine.us
HQ Phone
Get M.D., PHD. Ryan's Phone Numberphone_androidMobile
Get M.D., PHD. Ryan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77014Ct scan guidance for insertion of radiation therapy fields | 163 | 468 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 130 | 168 |
| 3 | 77263Complex radiation therapy planning | 103 | 107 |
| 4 | 77300Calculation of radiation therapy dose | 87 | 430 |
| 5 | 77334Design and construction of complex radiation treatment device | 87 | 212 |
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.
Authors: Daniel Olson, Mark Albertini, Christopher Barker, Maija Kiuru, Roxana Dronca, Jennifer Schwartz, Anthony Olszanski, Ryan Fields, Joel Baumgartner, Patrick Ott, Sunandana Chandra, Sarah Bateni, Joseph Skitzki, Bartosz Chmielowski, Merrick Ross, Genevieve Boland, Giorgos Karakousis, Kari Kendra, Luke Rothermel, Shailender Bhatia, Susan Swetter, Theodore Logan, Julie Lange
Journal: J Natl Compr Canc Netw
High-dose-rate brachytherapy of rhabdomyosarcoma limited to the external auditory canal.
Authors: Suzanne Wolden, Martin King
Publication Date: 2016-04-19
Lead Sponsor: University of Colorado, Denver
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Atezolizumab, RADIATION: Stereotactic Body Radiation Therapy
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, DRUG: Cisplatin, RADIATION: Intensity-Modulated Radiation Therapy
